SCHEMBL4968089

SCHEMBL4968089

CC(N)(c1cccc(OC(F)(F)F)c1)c1cccc(OC(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.50
KCNH2 Q12809 2/20 0.47
SCN10A Q9Y5Y9 1/20 0.47
CETP P11597 6/20 0.43
GRM5 P41594 1/20 0.40
CCR6 P51684 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
SLC22A12 Q96S37 1/20 0.38
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
MPI P34949 1/20 0.38
XDH P47989 1/20 0.38
NPC1 O15118 1/20 0.38
GMNN O75496 1/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL102298 0.85 KIF11 (0.49) KIF11KCNH2SCN10ACETPCCR6
SCHEMBL26965546 0.83 KIF11 (0.49) KIF11KCNH2SCN10ACETP
SCHEMBL27076801 0.83 KIF11 (0.49) KIF11KCNH2SCN10ACETP
SCHEMBL26965518 0.80 PKM (0.54) KIF11KCNH2SCN10ACETPCYP1A2
SCHEMBL11527555 0.80 KIF11 (0.51) KIF11CETPSLC6A2SLC6A3
SCHEMBL17552755 0.80 KIF11 (0.49) KIF11KCNH2SCN10ACETPCHRM2
SCHEMBL31177450 0.78 CETP (0.45) KIF11CETPNPC1GAAPKM
SCHEMBL26394699 0.77 KIF11 (0.43) KIF11KCNH2SCN10ACETPGRM5
SCHEMBL26394642 0.77 KIF11 (0.43) KIF11KCNH2SCN10ACETPGRM5
SCHEMBL18737497 0.77 KIF11 (0.47) KIF11KCNH2SCN10ACETPCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed